Leading Independent Proxy Advisory Firm ISS Recommends MMLP Unitholders Vote "FOR" the Transaction with MRMC

Stock Information for Lumos Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Lumos Pharma Inc.

Martin Midstream Partners Announces Retirement of VP Jeff Posey; Michael Lawrence to Expand Role Leading Sulfur and Fertilizer Services
Martin Midstream Partners L.P. to Participate in the Wells Fargo 24th Annual Energy and Power Symposium
Martin Midstream Partners Reports Third Quarter 2025 Financial Results, Declares Quarterly Cash Distribution and Withdraws Guidance
Martin Midstream Partners L.P. Sets Date for Release of Third Quarter 2025 Financial Results
Martin Midstream Partners L.P. Announces Amendment and Extension of Revolving Credit Facility
Martin Midstream Partners Reports Second Quarter 2025 Financial Results and Declares Quarterly Cash Distribution
Martin Midstream Partners L.P. Sets Date for Release of Second Quarter 2025 Financial Results
Martin Midstream Partners L.P. 2024 Schedule K-3 Forms Now Available

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.